RU95106890A - Method of prophylaxis of aerogenic infections caused by horse venezuelan encephalomyelitis, marburg and ebola viruses - Google Patents
Method of prophylaxis of aerogenic infections caused by horse venezuelan encephalomyelitis, marburg and ebola virusesInfo
- Publication number
- RU95106890A RU95106890A RU95106890/13A RU95106890A RU95106890A RU 95106890 A RU95106890 A RU 95106890A RU 95106890/13 A RU95106890/13 A RU 95106890/13A RU 95106890 A RU95106890 A RU 95106890A RU 95106890 A RU95106890 A RU 95106890A
- Authority
- RU
- Russia
- Prior art keywords
- reaferon
- ridostin
- aerogenic
- marburg
- prophylaxis
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
FIELD: medicine, virology. SUBSTANCE: method involves parenteral administration of preparations containing interferon inductor and/or immunomodulating agent before or at period of pathogen incorporation in organism by aerogenic way. These preparations were administrated by intranasal route simultaneously with parenteral administration at the same doses. Prophylaxis preparations: reaferon or ridostin, or reaferon with ridostin, or reaferon with polyribonate, or reaferon with ridostin and polyribonate that were administrated in organism twice per a day at the following total doses: reaferon (1.0-100.0) x 10IU/kg; ridostin 1.0-8.0 mg/kg, and polyribonate 10.0-100.0 mg/kg. Method is used for nonspecific immunoprophylaxis of viral infection. EFFECT: enhanced prophylaxis action. 4 tbl
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU95106890/13A RU2105565C1 (en) | 1995-04-28 | 1995-04-28 | Method of prophylaxis of viral aerogenic infections |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU95106890/13A RU2105565C1 (en) | 1995-04-28 | 1995-04-28 | Method of prophylaxis of viral aerogenic infections |
Publications (2)
Publication Number | Publication Date |
---|---|
RU95106890A true RU95106890A (en) | 1997-06-10 |
RU2105565C1 RU2105565C1 (en) | 1998-02-27 |
Family
ID=20167271
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU95106890/13A RU2105565C1 (en) | 1995-04-28 | 1995-04-28 | Method of prophylaxis of viral aerogenic infections |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2105565C1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2585695C1 (en) * | 2015-03-12 | 2016-06-10 | Закрытое акционерное общество "Вектор-Медика" (ЗАО "Вектор-Медика") | Method of inhibiting infectious activity of ebola virus in experiment |
-
1995
- 1995-04-28 RU RU95106890/13A patent/RU2105565C1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
RU2105565C1 (en) | 1998-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Milligan et al. | Interferon-γ enhances resolution of herpes simplex virus type 2 infection of the murine genital tract | |
WO1996006620A3 (en) | Lipid analogs for treating viral infections | |
MY133891A (en) | Polyethylene glycol modified interferon therapy | |
EA199800674A1 (en) | METHOD OF REPEATED TREATMENT OF PATIENTS WITH HEPATITIS C | |
DE60105424D1 (en) | METHODS FOR TREATING DELTA HEPATITIS VIRUS INFECTIONS WITH BETA-L-2 'DEOXY NUCLEOSIDES | |
AU4203201A (en) | Methods of suppressing hepatitis virus infection using immunomodulatory polynucleotide sequences | |
RU95110698A (en) | Method of treatment of infections caused by hepatitis b virus | |
HUP0300027A2 (en) | Nucleoside analogs with carboxamidine modified monocyclic base and process for their use | |
EA200000596A1 (en) | TAT HIV-1 OR ITS DERIVATIVES FOR PREVENTIVE AND MEDICAL VACCINATION | |
AU4358801A (en) | Methods of reducing papillomavirus infection using immunomodulatory polynucleotide sequences | |
DE69521880D1 (en) | ORAL ADMINISTRATION SYSTEM OF CHEMICAL-MODIFIED PROTEINS G-CSF | |
MY127808A (en) | Use of dideoxy nucleoside analogues in the treatment of viral infections | |
RU2150281C1 (en) | Method of treatment of calves with respiratory disease | |
RU95106890A (en) | Method of prophylaxis of aerogenic infections caused by horse venezuelan encephalomyelitis, marburg and ebola viruses | |
US20070122384A1 (en) | Method for treating inflammatory bowel disease | |
ES2105923A1 (en) | Compositions containing 5-iodouracil derivatives for the treatment of hepatitis B infections. | |
FI954127A0 (en) | A method for treating hepatitis C in patients who do not respond to interferon therapy | |
Moya et al. | Immunomodulatory activity of isoprinosine on experimental viral infections in avian models | |
AU4712993A (en) | New peptides, antibodies raised against peptides and means for blocking said antibodies, application as medicaments, pharmaceutical compositions and utilization methods | |
RU93058325A (en) | APPLICATION OF 1,3-OXATHIOLANE DERIVATIVES FOR PRODUCTION OF MEDICINES FOR THE TREATMENT OR PREVENTION OF HEPATITIS B VIRAL INFECTION, APPLICATION OF 1,3 - OXATHYOLANE DERIVATIVES FOR THE TREATMENT OF HEPATITIS | |
GR3024236T3 (en) | Use of leukoregulin for the treatment of animals infected with an envelope-virus | |
GR3006999T3 (en) | ||
Straub | Studies on the suitability of alpha-hybrid interferon application in cattle | |
Wrzos et al. | Effect of antibody to interferon on genital herpesvirus infection in mice | |
GR3035004T3 (en) | Method and composition for the treatment of herpes related disorders. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20060429 |